BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

414 related articles for article (PubMed ID: 22670872)

  • 1. MMP proteolysis of the human extracellular matrix protein aggrecan is mainly a process of normal turnover.
    Struglics A; Hansson M
    Biochem J; 2012 Sep; 446(2):213-23. PubMed ID: 22670872
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Calpain is involved in C-terminal truncation of human aggrecan.
    Struglics A; Hansson M
    Biochem J; 2010 Sep; 430(3):531-8. PubMed ID: 20618160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human aggrecanase generated synovial fluid fragment levels are elevated directly after knee injuries due to proteolysis both in the inter globular and chondroitin sulfate domains.
    Struglics A; Hansson M; Lohmander LS
    Osteoarthritis Cartilage; 2011 Aug; 19(8):1047-57. PubMed ID: 21664283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human osteoarthritis synovial fluid and joint cartilage contain both aggrecanase- and matrix metalloproteinase-generated aggrecan fragments.
    Struglics A; Larsson S; Pratta MA; Kumar S; Lark MW; Lohmander LS
    Osteoarthritis Cartilage; 2006 Feb; 14(2):101-13. PubMed ID: 16188468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and characterization of a highly specific and sensitive sandwich ELISA for detection of aggrecanase-generated aggrecan fragments.
    Pratta MA; Su JL; Leesnitzer MA; Struglics A; Larsson S; Lohmander LS; Kumar S
    Osteoarthritis Cartilage; 2006 Jul; 14(7):702-13. PubMed ID: 16549371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aggrecanase cleavage in juvenile idiopathic arthritis patients is minimally detected in the aggrecan interglobular domain but robust at the aggrecan C-terminus.
    Struglics A; Lohmander LS; Last K; Akikusa J; Allen R; Fosang AJ
    Arthritis Rheum; 2012 Dec; 64(12):4151-61; author reply 4162-3. PubMed ID: 22886575
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aggrecanase and aggrecan degradation in osteoarthritis: a review.
    Huang K; Wu LD
    J Int Med Res; 2008; 36(6):1149-60. PubMed ID: 19094423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aggrecan degradation in human cartilage. Evidence for both matrix metalloproteinase and aggrecanase activity in normal, osteoarthritic, and rheumatoid joints.
    Lark MW; Bayne EK; Flanagan J; Harper CF; Hoerrner LA; Hutchinson NI; Singer II; Donatelli SA; Weidner JR; Williams HR; Mumford RA; Lohmander LS
    J Clin Invest; 1997 Jul; 100(1):93-106. PubMed ID: 9202061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of aggrecan in human knee cartilage and synovial fluid indicates that aggrecanase (ADAMTS) activity is responsible for the catabolic turnover and loss of whole aggrecan whereas other protease activity is required for C-terminal processing in vivo.
    Sandy JD; Verscharen C
    Biochem J; 2001 Sep; 358(Pt 3):615-26. PubMed ID: 11535123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of covalently attached chondroitin sulfate on aggrecan cleavage by ADAMTS-4 and MMP-13.
    Miwa HE; Gerken TA; Hering TM
    Matrix Biol; 2006 Oct; 25(8):534-45. PubMed ID: 16945513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aggrecanase versus matrix metalloproteinases in the catabolism of the interglobular domain of aggrecan in vitro.
    Little CB; Flannery CR; Hughes CE; Mort JS; Roughley PJ; Dent C; Caterson B
    Biochem J; 1999 Nov; 344 Pt 1(Pt 1):61-8. PubMed ID: 10548534
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a novel clinical biomarker assay to detect and quantify aggrecanase-generated aggrecan fragments in human synovial fluid, serum and urine.
    Swearingen CA; Carpenter JW; Siegel R; Brittain IJ; Dotzlaf J; Durham TB; Toth JL; Laska DA; Marimuthu J; Liu C; Brown DP; Carter QL; Wiley MR; Duffin KL; Mitchell PG; Thirunavukkarasu K
    Osteoarthritis Cartilage; 2010 Sep; 18(9):1150-8. PubMed ID: 20633682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MMPs are less efficient than ADAMTS5 in cleaving aggrecan core protein.
    Durigova M; Nagase H; Mort JS; Roughley PJ
    Matrix Biol; 2011 Mar; 30(2):145-53. PubMed ID: 21055468
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Products resulting from cleavage of the interglobular domain of aggrecan in samples of synovial fluid collected from dogs with early- and late-stage osteoarthritis.
    Innes JF; Little CB; Hughes CE; Caterson B
    Am J Vet Res; 2005 Oct; 66(10):1679-85. PubMed ID: 16273897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intraarticular Matrix Metalloproteinases and Aggrecan Degradation Are Elevated After Articular Fracture.
    Haller JM; Swearingen CA; Partridge D; McFadden M; Thirunavukkarasu K; Higgins TF
    Clin Orthop Relat Res; 2015 Oct; 473(10):3280-8. PubMed ID: 26162411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of protease inhibitors on the induction of osteoarthritis-related biomarkers in bovine full-depth cartilage explants.
    He Y; Zheng Q; Jiang M; Sun S; Christiansen TG; Kassem M; Karsdal MA; Bay-Jensen AC
    PLoS One; 2015; 10(4):e0122700. PubMed ID: 25909781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Turnover of type II collagen and aggrecan in cartilage matrix at the onset of inflammatory arthritis in humans: relationship to mediators of systemic and local inflammation.
    Fraser A; Fearon U; Billinghurst RC; Ionescu M; Reece R; Barwick T; Emery P; Poole AR; Veale DJ
    Arthritis Rheum; 2003 Nov; 48(11):3085-95. PubMed ID: 14613270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin-1alpha treatment of meniscal explants stimulates the production and release of aggrecanase-generated, GAG-substituted aggrecan products and also the release of pre-formed, aggrecanase-generated G1 and m-calpain-generated G1-G2.
    Lemke AK; Sandy JD; Voigt H; Dreier R; Lee JH; Grodzinsky AJ; Mentlein R; Fay J; Schünke M; Kurz B
    Cell Tissue Res; 2010 Apr; 340(1):179-88. PubMed ID: 20217136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of matrix metalloproteinases 2, 9, and 13 by activated protein C in human osteoarthritic cartilage chondrocytes.
    Jackson MT; Moradi B; Smith MM; Jackson CJ; Little CB
    Arthritis Rheumatol; 2014 Jun; 66(6):1525-36. PubMed ID: 24574263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of extracellular matrix from articular cartilage is mediated by the synovium and ligament after anterior cruciate ligament injury.
    Haslauer CM; Elsaid KA; Fleming BC; Proffen BL; Johnson VM; Murray MM
    Osteoarthritis Cartilage; 2013 Dec; 21(12):1950-7. PubMed ID: 24036379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.